GlassScriptPhysician profile
Steven Paul Proper
NPI 1508812983
$2,395.66
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,089 · 2020: $334 · 2021: $427 · 2022: $155 · 2023: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $797.87 | 2020-2023 | |
| Abbvie INC. | $431.04 | 2019-2020 | |
| Genentech USA, INC. | $258.75 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $202.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $133.87 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $103.65 | 2019-2020 | |
| Genzyme Corporation | $81.80 | 2019-2021 | |
| Ucb, INC. | $75.79 | 2020-2021 | |
| Janssen Biotech, INC. | $71.60 | 2019-2020 | |
| Biofrontera INC. | $50.37 | 2019 | |
| Leo Pharma INC. | $49.98 | 2019 | |
| Encore Dermatology INC. | $25.72 | 2019 | |
| Merck Sharp & Dohme LLC | $23.93 | 2019 | |
| Pfizer INC. | $22.35 | 2019 | |
| Integra Lifesciences Corporation | $22.06 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $20.20 | 2019 | |
| Dusa Pharmaceuticals, INC. | $11.99 | 2019 | |
| Smith+Nephew, INC. | $11.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Proper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.